Categories for... Drug Discovery

News Targeted Protein Degradation

Sygnature Discovery and UBE Corporation successfully identify potent SHP2 degrader compounds

READ ARTICLE

Drug Discovery News

Five Arrows invests in Sygnature Discovery

READ ARTICLE

Drug Discovery News

Sygnature Discovery’s Early CMC Development Expansion: Unveiling New Opportunities

READ ARTICLE

Drug Discovery News

Sygnature Discovery expands US presence with Bay Area office

READ ARTICLE

DMPK in vivo pharmacology News

Leading UK Drug Discovery CROs Unite as Sygnature Discovery

READ ARTICLE

Drug Discovery News

Sygnature Discovery Opens Second Drug Discovery Site at Alderley Park

READ ARTICLE

Computational Sciences and Informatics Drug Discovery News

Enhancing Molecular Design Services: Sygnature Discovery Adopts OpenEye’s Orion™ Platform

READ ARTICLE

Bioscience News

Sygnature upgrades western blotting capability with Jess instrument from Protein Simple

READ ARTICLE

Drug Discovery News

Sygnature assists New York Medical College in the fight against Covid-19

READ ARTICLE

Bioscience Drug Discovery News

Sygnature Discovery Enhances SPR Capacity with Expansion

READ ARTICLE

Bioscience News

Sygnature Discovery test-drives SPR-M

READ ARTICLE

Computational Sciences and Informatics Drug Discovery News

Sygnature Discovery announces collaboration with software firm SilcsBio

READ ARTICLE